SCHEMBL30925652

SCHEMBL30925652

COC(=O)/C=C\CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91342 1.00
SCHEMBL9003282 1.00
Hydrochloric Acid SCHEMBL18047418 0.98
Hydrochloric Acid SCHEMBL18047416 0.98
Trifluoroacetic Acid SCHEMBL29728619 0.86 GABRR1 (0.43)
SCHEMBL27439377 0.81
Hydrochloric Acid SCHEMBL31127727 0.79 HCAR2 (0.50)
SCHEMBL3144798 0.77
SCHEMBL690353 0.77
SCHEMBL10054177 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250026721-A1 COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K VIVIDION THERAPEUTICS, INC. 2025-01-23 US disclosed
WO-2024086132-A1 PROTACS TARGETING VIRAL ENZYMES FOR PRECISE TREATMENT OF COVID-19 OHIO UNIVERSITY (US) 2024-04-25 WO disclosed